XIAP and breast cancer: Another SMAC mimetic, called AZ58, led to a reduction of cIAP1, cIAP2 and XIAP expression, sensitized different BC cell lines to gemcitabine and cisplatin, and caused inhibition of tumor growth in a UMUC-6 mouse xenograft model (40).